Cite
MLA Citation
Nicolas Epaillard et al.. “Pleural effusion is a negative prognostic factor for immunotherapy in patients with non-small cell lung cancer (NSCLC): The pluie study.” Lung cancer, vol. 155, 2021, pp. 114–119. http://access.bl.uk/ark:/81055/vdc_100129506088.0x000047